Data as of Oct 28, 2026.
LYTE vs XBI: Differences, Returns & Fees
LYTE and XBI are compared on the fields both publish.
askIQ about this page
askIQ about LYTE and XBINet assets: $165m on Oct 28, 2026 for Roundhill Photonics & Optics ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.
Pair scorecard
XBI costs 0.30 points a year less; XBI is far larger, $10.3bn against $163m.
| Measure | LYTE | XBI |
|---|---|---|
| Return | ||
| Total return, 1 year | not published | +41.2% |
| Drawdown | ||
| Below its all-time high | 28.5%, high on Aug 17, 2026 | 8.9%, high on Feb 8, 2021 |
| Benchmark | ||
| What it tracks | Photonics and optics | Biotech |
| Cost and size | ||
| Expense ratio | 0.65% | 0.35% |
| Net assets, as of Oct 27, 2026 | $163m | $10.3bn |
| Active share vs the S&P 500 | 98% | |
| Holdings | ||
| Holdings in common | not published | |
| In the S&P 500, by weight | 13% | |
| Top ten holdings, share of the fund | 18% | |
Side by side
LYTE and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.
LYTE
LYTE has no public holdings filing captured yet. Since it first traded on Aug 6, 2026 the fund returned −19.6% with distributions reinvested. It sits 28.5% below its all-time high of Aug 17, 2026.
XBI
By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.
Questions people ask
- Which is cheaper, LYTE or XBI?
- XBI is cheaper, by 0.30 percentage points a year. That is about $30 on $10,000 held for a year. Fees come from each fund's prospectus.
Links are sources, not endorsements. A comparison is not a recommendation.
Cite this pageCitation, APA and Markdown
ETFIQ, LYTE against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/lyte-vs-xbi
ETFIQ. (Oct 28, 2026). LYTE against XBI. Retrieved from https://etfiq.com/compare/any/lyte-vs-xbi
[LYTE against XBI (ETFIQ, Oct 28, 2026)](https://etfiq.com/compare/any/lyte-vs-xbi)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.